Telomir Pharmaceuticals CFO departs, replaced by fractional consultant at $6K/month

Filed June 8, 2026 · Period ending June 3, 2026 · ~1 min read

Key Changes

• medium

  CFO Alan Weichselbaum departed effective June 6, 2026. Company states departure was not due to any disagreement on operations, policies, or practices.

  Item 5.02 verify on EDGAR →
• medium

  Andriy Mushak appointed fractional CFO at $6,000/month through consulting firm LMAM, rather than as full-time employee. Mushak is a CPA with 20+ years SEC reporting experience.

  Item 5.02 verify on EDGAR →
• medium

  Fractional CFO structure may signal cost management or transitional arrangement rather than permanent executive hire.

  Item 5.02 verify on EDGAR →